Huawei Confirms 4-Year Push for Blood-Sugar Device as Watch GT 7 Adds Diabetes Risk Study
Updated
Updated · Wareable · Oct 1
Huawei Confirms 4-Year Push for Blood-Sugar Device as Watch GT 7 Adds Diabetes Risk Study
3 articles · Updated · Wareable · Oct 1
Summary
Watch GT 7 and 7 Pro users in the Middle East, Africa and parts of Europe are receiving an over-the-air Diabetes Risk Study update through Huawei Research.
The feature uses the watch’s standard PPG optical sensor over a required 3- to 14-day wear period, combining pulse-wave patterns with age, sex, height and weight to generate a diabetes risk assessment.
Huawei says the tool does not measure blood glucose or guide treatment, positioning it instead as an early-warning screen for users who may need formal medical follow-up.
He Gang said a dedicated blood-sugar testing device is also in development after four years of R&D, signaling Huawei’s push beyond predictive algorithms toward direct, non-invasive glucose monitoring.